194 related articles for article (PubMed ID: 1359584)
41. Biochemical studies in suicide victims: current findings and future implications.
Stanley M; Stanley B
Suicide Life Threat Behav; 1989; 19(1):30-42. PubMed ID: 2565612
[No Abstract] [Full Text] [Related]
42. 5-HT: on the psychiatrist's couch.
Briley M; Grahame-Smith D
Trends Pharmacol Sci; 1992 Sep; 13(9):337-8. PubMed ID: 1326798
[No Abstract] [Full Text] [Related]
43. Genetic variations and association.
Gennarelli M; Cattaneo A
Int Rev Neurobiol; 2010; 94():129-51. PubMed ID: 21081205
[No Abstract] [Full Text] [Related]
44. Serotonin-based therapeutics.
Higgins GA; Fletcher PJ
Pharmacol Biochem Behav; 2002 Apr; 71(4):531-2. PubMed ID: 11888545
[No Abstract] [Full Text] [Related]
45. Evolutionary conservation of the 5-HT2B receptors.
Colas JF; Choi DS; Launay JM; Maroteaux L
Ann N Y Acad Sci; 1997 May; 812():149-53. PubMed ID: 9186729
[No Abstract] [Full Text] [Related]
46. [Interneuronal homeostasis as an etiopathogenic factor in mental disease].
Veramendi Eguilaz V
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1979; 7(1):55-64. PubMed ID: 34985
[No Abstract] [Full Text] [Related]
47. Transcriptional control of serotonin-modulated behavior and physiology.
Liu C; Deneris ES
Neuropsychopharmacology; 2011 Jan; 36(1):361-2. PubMed ID: 21116255
[No Abstract] [Full Text] [Related]
48. The classification of 5-hydroxytryptamine receptors.
Leff P; Martin GR
Med Res Rev; 1988; 8(2):187-202. PubMed ID: 3288820
[No Abstract] [Full Text] [Related]
49. 5-hydroxytryptamine and psychiatric illness.
Lancet; 1981 Oct; 2(8250):788-9. PubMed ID: 6116911
[No Abstract] [Full Text] [Related]
50. The biochemistry of mental illness.
Smith BH; Rosich-Pla A
Psychosomatics; 1979 Apr; 20(4):278-9, 282-3. PubMed ID: 35811
[No Abstract] [Full Text] [Related]
51. Amine precursor therapy: manipulation of brain amine activity with precursor amino acid.
Nakajima T
Psychiatry Clin Neurosci; 1997 Oct; 51(5):267-74. PubMed ID: 9413872
[TBL] [Abstract][Full Text] [Related]
52. [Serotonin and psychiatry].
BUSCAINO GA
Acta Neurol (Napoli); 1961; 16():93-117. PubMed ID: 13689315
[No Abstract] [Full Text] [Related]
53. Neurotransmitters and viruses.
Sutton RN; Itzhaki RF
Lancet; 1983 Jan; 1(8316):124. PubMed ID: 6129435
[No Abstract] [Full Text] [Related]
54. Serotonin receptor subtypes.
Hartig PR; Adham N; Zgombick J; Macchi M; Kao HT; Schechter L; Branchek T; Weinshank R
Psychopharmacol Ser; 1993; 10():15-25. PubMed ID: 8361973
[No Abstract] [Full Text] [Related]
55. [Chromatographic determination of metabolites of serotonin in various mental disorders].
SOLDUGA CAMARERO FJ
Laboratorio; 1962 May; 33():407-15. PubMed ID: 13914931
[No Abstract] [Full Text] [Related]
56. Impact of the human genome project on the principles for classification and nomenclature of 5-HT receptors.
Hoyer D; Humphrey PA; Barnard EA
Ann N Y Acad Sci; 1998 Dec; 861():230-1. PubMed ID: 9928260
[No Abstract] [Full Text] [Related]
57. The ABCs of psychobiology.
Keltner NL
Perspect Psychiatr Care; 2003; 39(3):123-6. PubMed ID: 14606233
[No Abstract] [Full Text] [Related]
58. [Psychochemistry].
Trompen WP
Tijdschr Ziekenverpl; 1966 May; 19(9):297-304. PubMed ID: 5176942
[No Abstract] [Full Text] [Related]
59. Editorial. Thematic section: serotonin and its receptors.
Albert PR
Int J Neuropsychopharmacol; 2014 Nov; 17(11):1727-8. PubMed ID: 25266038
[No Abstract] [Full Text] [Related]
60. Characterization of a novel RNAi yeast insecticide that silences mosquito 5-HT1 receptor genes.
Mysore K; Njoroge TM; Stewart ATM; Winter N; Hamid-Adiamoh M; Sun L; Feng RS; James LD; Mohammed A; Severson DW; Duman-Scheel M
Sci Rep; 2023 Dec; 13(1):22511. PubMed ID: 38110471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
